Original Publication
Open Access

Pharmacologic Interventions in Postpartum Hemorrhage

Published: June 24, 2010 | 10.15766/mep_2374-8265.8024

Included in this publication:

  • Instructor's Guide.docx
  • PPH_Module_Uterotonics
  • User Guide Interventions.docx

To view all publication components, extract (i.e., unzip) them from the downloaded .zip file.

Editor's Note: This publication predates our implementation of the Educational Summary Report in 2016 and thus displays a different format than newer publications.


This resource is an audiovisual tutorial for pharmacologic management of postpartum hemorrhage. This module was prepared for use in residencies with significant obstetrical training but is appropriate for use by any individual seeking detailed information on pharmacologic management of postpartum hemorrhage. It can be used in conjunction with postpartum hemorrhage simulation, in support of didactic sessions, and as a stand-alone discussion or review of the subject matter. The presentation contains a narrated slide set with embedded summary tables. There is a transcription of all audio narration so that the resource is usable by the hearing impaired. This module was developed as part of a comprehensive blended learning curriculum for teaching the management of postpartum hemorrhage. The full curriculum included seven online modules followed by face-to-face teaching and learning with task trainers and a multidisciplinary simulation case. Project-associated pre- and posttesting demonstrated clear improvement in mastery of material as a result of using this module. All trainees completing the module reported that the module increased their knowledge “moderately” or “to a great extent.” Additionally, all trainees reported that they “agreed” or “strongly agreed” that they would recommend the module to another learner.

Educational Objectives

By the end of this resource, learners should be able to:

  1. Identify when to initiate uterotonics during postpartum hemorrhage.
  2. Name the three classes of uterotonics.
  3. Verbalize correct dose and dosing interval for each medication.
  4. Describe contraindications regarding various uterotonics.
  5. Verbalize indications for, correct dose of, and risks of using human recombinant factor VIIa.

Author Information

  • Dawn Tasillo, MD: University of Massachusetts Medical School
  • Tiffany Moore Simas, MD, MPH, MEd: University of Massachusetts
  • Lyn Riza, MS: university of massachusetts medical school
  • Susan Pasquale, PhD: university of massachusetts medical school
  • Robert Berry Jr, MD: university of massachusetts medical school
  • Mark Manning, DO: university of massachusetts medical school

None to report.

None to report.


Tasillo D, Moore Simas T, Riza L, Pasquale S, Berry Jr R, Manning M. Pharmacologic interventions in postpartum hemorrhage. MedEdPORTAL. 2010;6:8024. https://doi.org/10.15766/mep_2374-8265.8024